Amedisys Home Health Care | |
1401 Mercantile Lane Suite 351, Largo, Maryland 20774 | |
(301) 322-6023 | |
Name | Amedisys Home Health Care |
---|---|
Location | 1401 Mercantile Lane Suite 351, Largo, Maryland |
Certified By | Medicare |
Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
Medicare ID | 217149 |
Ownership Type | Proprietary |
Service Area Zip Codes | 20607, 20613, 20623, 20705, 20706, 20707, 20708, 20710, 20712, 20715, 20716, 20719, 20720, 20721, 20723, 20724, 20735, 20737, 20740, 20742, 20743, 20744, 20745, 20746, 20747, 20748, 20769, 20770, 20772, 20774, 20781, 20782, 20783, 20784, 20785, 20814, 20815, 20816, 20817, 20818, 20832, 20833, 20841, 20842, 20850, 20851, 20852, 20853, 20854, 20855, 20866, 20868, 20871, 20872, 20874, 20876, 20877, 20878, 20879, 20882, 20886, 20895, 20901, 20902, 20903, 20904, 20905, 20906, 20910, 20912, 20918 |
NPI Number | 1316490816 |
Organization Name | LOVE ONE HOME HEALTHCARE, INC. |
Address | 1401 Mercantile Ln, 200-j, Largo, MD 20774 |
Phone Number | 301-773-4595 |
News Archive
The trauma from hard combat can devastate veterans until old age, even as it influences others to be wiser, gentler and more accepting in their twilight years, a new University of Florida study finds.
Royal Philips and its ACT-program consortium partners today announced the debut of a ‘cookbook' outlining key enablers necessary to scale connected care and telehealth programs.
A multi-institutional team headed by Ursula Bellugi, professor and director of the Laboratory for Cognitive Neuroscience at the Salk Institute for Biological Studies, has been awarded a $5.5 million Program Project Grant by the National Institute of Child Health and Human Development to link social behavior to its underlying neurobiological and molecular genetic basis using Williams syndrome as a model.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that tumor necrosis factor (TNF)-alpha inhibitors will continue to dominate first- and second-line biologic therapy for the treatment of rheumatoid arthritis in the United States through 2011, but the more established branded drugs such as, Centocor Ortho Biotech's Remicade, Abbott's Humira and Amgen/Wyeth's Enbrel, in this class will face competition from newer entrants.
› Verified 8 days ago
NPI Number | 1831143908 |
Organization Name | TENDER LOVING CARE HEALTH CARE SERVICES SOUTHEAST, LLC |
Doing Business As | AMEDISYS HOME HEALTH CARE |
Address | 1401 Mercantile Ln, Suite 351, Largo, MD 20774 |
Phone Number | 301-322-6023 |
News Archive
The trauma from hard combat can devastate veterans until old age, even as it influences others to be wiser, gentler and more accepting in their twilight years, a new University of Florida study finds.
Royal Philips and its ACT-program consortium partners today announced the debut of a ‘cookbook' outlining key enablers necessary to scale connected care and telehealth programs.
A multi-institutional team headed by Ursula Bellugi, professor and director of the Laboratory for Cognitive Neuroscience at the Salk Institute for Biological Studies, has been awarded a $5.5 million Program Project Grant by the National Institute of Child Health and Human Development to link social behavior to its underlying neurobiological and molecular genetic basis using Williams syndrome as a model.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that tumor necrosis factor (TNF)-alpha inhibitors will continue to dominate first- and second-line biologic therapy for the treatment of rheumatoid arthritis in the United States through 2011, but the more established branded drugs such as, Centocor Ortho Biotech's Remicade, Abbott's Humira and Amgen/Wyeth's Enbrel, in this class will face competition from newer entrants.
› Verified 8 days ago
NPI Number | 1962725952 |
Organization Name | TENDER LOVING CARE HEALTH CARE SERVICES SOUTHEAST, L.L.C. |
Doing Business As | AMEDISYS HOME HEALTH CARE |
Address | 1401 Mercantile Ln, Suite 351, Largo, MD 20774 |
Phone Number | 301-322-6023 |
News Archive
The trauma from hard combat can devastate veterans until old age, even as it influences others to be wiser, gentler and more accepting in their twilight years, a new University of Florida study finds.
Royal Philips and its ACT-program consortium partners today announced the debut of a ‘cookbook' outlining key enablers necessary to scale connected care and telehealth programs.
A multi-institutional team headed by Ursula Bellugi, professor and director of the Laboratory for Cognitive Neuroscience at the Salk Institute for Biological Studies, has been awarded a $5.5 million Program Project Grant by the National Institute of Child Health and Human Development to link social behavior to its underlying neurobiological and molecular genetic basis using Williams syndrome as a model.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that tumor necrosis factor (TNF)-alpha inhibitors will continue to dominate first- and second-line biologic therapy for the treatment of rheumatoid arthritis in the United States through 2011, but the more established branded drugs such as, Centocor Ortho Biotech's Remicade, Abbott's Humira and Amgen/Wyeth's Enbrel, in this class will face competition from newer entrants.
› Verified 8 days ago
Quality Rating: |
News Archive
The trauma from hard combat can devastate veterans until old age, even as it influences others to be wiser, gentler and more accepting in their twilight years, a new University of Florida study finds.
Royal Philips and its ACT-program consortium partners today announced the debut of a ‘cookbook' outlining key enablers necessary to scale connected care and telehealth programs.
A multi-institutional team headed by Ursula Bellugi, professor and director of the Laboratory for Cognitive Neuroscience at the Salk Institute for Biological Studies, has been awarded a $5.5 million Program Project Grant by the National Institute of Child Health and Human Development to link social behavior to its underlying neurobiological and molecular genetic basis using Williams syndrome as a model.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that tumor necrosis factor (TNF)-alpha inhibitors will continue to dominate first- and second-line biologic therapy for the treatment of rheumatoid arthritis in the United States through 2011, but the more established branded drugs such as, Centocor Ortho Biotech's Remicade, Abbott's Humira and Amgen/Wyeth's Enbrel, in this class will face competition from newer entrants.
› Verified 8 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often the home health team began their patients’ care in a timely manner | 98.6 | 95.7 |
How often the home health team taught patients (or their family caregivers) about their drugs | 99.9 | 98.6 |
How often the home health team checked patients’ risk of falling | 99.6 | 99.6 |
How often the home health team checked patients for depression | 95.7 | 97.4 |
How often the home health team made sure that their patients have received a flu shot for the current flu season. | 73.4 | 78.7 |
How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 74.9 | 82.2 |
With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 99.1 | 96.4 |
News Archive
The trauma from hard combat can devastate veterans until old age, even as it influences others to be wiser, gentler and more accepting in their twilight years, a new University of Florida study finds.
Royal Philips and its ACT-program consortium partners today announced the debut of a ‘cookbook' outlining key enablers necessary to scale connected care and telehealth programs.
A multi-institutional team headed by Ursula Bellugi, professor and director of the Laboratory for Cognitive Neuroscience at the Salk Institute for Biological Studies, has been awarded a $5.5 million Program Project Grant by the National Institute of Child Health and Human Development to link social behavior to its underlying neurobiological and molecular genetic basis using Williams syndrome as a model.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that tumor necrosis factor (TNF)-alpha inhibitors will continue to dominate first- and second-line biologic therapy for the treatment of rheumatoid arthritis in the United States through 2011, but the more established branded drugs such as, Centocor Ortho Biotech's Remicade, Abbott's Humira and Amgen/Wyeth's Enbrel, in this class will face competition from newer entrants.
› Verified 8 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often patients got better at walking or moving around | 84 | 79.6 |
How often patients got better at getting in and out of bed | 87.8 | 81.1 |
How often patients got better at bathing | 86 | 82.3 |
How often patients’ breathing improved | 97 | 82.8 |
How often patients’ wounds improved or healed after an operation | 93.3 | 92.3 |
How often patients got better at taking their drugs correctly by mouth | 79.5 | 75 |
How often home health patients had to be admitted to the hospital | 14.8 | 15.4 |
How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 13.7 | 13 |
How often physician-recommended actions to address medication issues were completely timely | 96.6 | 94 |
News Archive
The trauma from hard combat can devastate veterans until old age, even as it influences others to be wiser, gentler and more accepting in their twilight years, a new University of Florida study finds.
Royal Philips and its ACT-program consortium partners today announced the debut of a ‘cookbook' outlining key enablers necessary to scale connected care and telehealth programs.
A multi-institutional team headed by Ursula Bellugi, professor and director of the Laboratory for Cognitive Neuroscience at the Salk Institute for Biological Studies, has been awarded a $5.5 million Program Project Grant by the National Institute of Child Health and Human Development to link social behavior to its underlying neurobiological and molecular genetic basis using Williams syndrome as a model.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that tumor necrosis factor (TNF)-alpha inhibitors will continue to dominate first- and second-line biologic therapy for the treatment of rheumatoid arthritis in the United States through 2011, but the more established branded drugs such as, Centocor Ortho Biotech's Remicade, Abbott's Humira and Amgen/Wyeth's Enbrel, in this class will face competition from newer entrants.
› Verified 8 days ago
Question Type: | Rating by Patients |
---|---|
Health team gave care in a professional way | |
Health team communicated well with them | |
Health team discussed medicines, pain, and home safety | |
How patients rated overall care from agency |
News Archive
The trauma from hard combat can devastate veterans until old age, even as it influences others to be wiser, gentler and more accepting in their twilight years, a new University of Florida study finds.
Royal Philips and its ACT-program consortium partners today announced the debut of a ‘cookbook' outlining key enablers necessary to scale connected care and telehealth programs.
A multi-institutional team headed by Ursula Bellugi, professor and director of the Laboratory for Cognitive Neuroscience at the Salk Institute for Biological Studies, has been awarded a $5.5 million Program Project Grant by the National Institute of Child Health and Human Development to link social behavior to its underlying neurobiological and molecular genetic basis using Williams syndrome as a model.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that tumor necrosis factor (TNF)-alpha inhibitors will continue to dominate first- and second-line biologic therapy for the treatment of rheumatoid arthritis in the United States through 2011, but the more established branded drugs such as, Centocor Ortho Biotech's Remicade, Abbott's Humira and Amgen/Wyeth's Enbrel, in this class will face competition from newer entrants.
› Verified 8 days ago
The patient survey data of Amedisys Home Health Care is compared against the national average with the color code indicators: Better than National Average Worse than National AverageExperience Measure | Provider | National Avg. |
---|---|---|
Percent of patients who reported that their home health team gave care in a professional way | 85 | 88 |
Percent of patients who reported that their home health team communicated well with them | 83 | 85 |
Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 83 | 83 |
Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 78 | 84 |
Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 69 | 78 |
News Archive
The trauma from hard combat can devastate veterans until old age, even as it influences others to be wiser, gentler and more accepting in their twilight years, a new University of Florida study finds.
Royal Philips and its ACT-program consortium partners today announced the debut of a ‘cookbook' outlining key enablers necessary to scale connected care and telehealth programs.
A multi-institutional team headed by Ursula Bellugi, professor and director of the Laboratory for Cognitive Neuroscience at the Salk Institute for Biological Studies, has been awarded a $5.5 million Program Project Grant by the National Institute of Child Health and Human Development to link social behavior to its underlying neurobiological and molecular genetic basis using Williams syndrome as a model.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that tumor necrosis factor (TNF)-alpha inhibitors will continue to dominate first- and second-line biologic therapy for the treatment of rheumatoid arthritis in the United States through 2011, but the more established branded drugs such as, Centocor Ortho Biotech's Remicade, Abbott's Humira and Amgen/Wyeth's Enbrel, in this class will face competition from newer entrants.
› Verified 8 days ago
Amedisys Home Health Care Location: 1401 Mercantile Lane Suite 351, Largo, Maryland 20774 Ratings: Phone: (301) 322-6023 |